Search academic texts

Information × Registration Number 0303U001412, 0199U000697 , R & D reports Title To improve the results of therapy of thyroid cancer on the basis of restoration of endocrine function of thymus and hypophysial and thyroid system of organism popup.stage_title Розробка показань до сумісного застосування препаратів тимуса та тиреоїдних гормонів у хворих на рак щитовидної залози після видалення пухлини Head Procyk V.S., Registration Date 28-02-2003 Organization Ukrainian Research Institute of Oncology and Radiology popup.description2 Removal of thymus results in some changes in hormonal and immune status of patients with pathologies of thymus. Used schedule of therapy of thyroid cancer patients with preparations of thymic origin resulted in increase of endocrine thymic function and accumulation of TSF inhibitors in patients' blood, normalization of CD8+, increase of total amount of E-RFC in patients with low ascending value and with availability of sensitivity of E-RFC to thymulin in vitro. Inclusion of thymulin into schedule of therapy of thyroid cancer patients normalizes functional activity of neutrophiles but doesn't restore their metabolic activity. After immunotherapy in patients with cancer and benign tumors of thyroid gland improvement of general state, improvement of life strength took place. Patients who received immunotherapy postoperatively, had Karnovsky index 10-20% higher than patients of control group who didn't receive it.56355635 Product Description popup.authors popup.nrat_date 2020-04-02 Close